Ameriprise Financial, Inc. 13D and 13G filings for Anika Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 10:33 am Sale | 2022-12-31 | 13G | Anika Therapeutics, Inc. ANIK | AMERIPRISE FINANCIAL INC AMP | 181,943 1.250% | -805,790 (-81.58%) | Filing |
| 2022-02-14 12:27 pm Sale | 2021-12-31 | 13G | Anika Therapeutics, Inc. ANIK | AMERIPRISE FINANCIAL INC AMP | 987,733 6.840% | -16,375 (-1.63%) | Filing |
| 2021-02-12 09:45 am Purchase | 2020-12-31 | 13G | Anika Therapeutics, Inc. ANIK | AMERIPRISE FINANCIAL INC AMP | 1,004,108 7.070% | 1,004,108 (New Position) | Filing |